How antidepressants and caffeine triggered mania in one patient

This case study examines a 42-year-old patient with no prior psychiatric history who experienced acute mania after accidentally taking double the prescribed dose of fluoxetine (an SSRI antidepressant) combined with high caffeine intake. The patient presented with classic manic symptoms including elevated mood, grandiosity, pressured speech, and significantly reduced sleep needs. Laboratory testing revealed the only notable finding was cannabis present in urine drug screening, while other tests remained unremarkable.

The case highlights an important drug-drug interaction between fluoxetine and caffeine that can destabilize mood and trigger psychiatric episodes in vulnerable individuals. The mechanism may involve fluoxetine's inhibition of CYP1A2, an enzyme responsible for metabolizing caffeine, potentially causing caffeine to accumulate to harmful levels and amplify stimulant effects. The patient improved after fluoxetine was discontinued and mood stabilizers (valproate and haloperidol) were administered.

This research underscores the importance of careful medication dosing and assessing stimulant use—including caffeine consumption—when evaluating new-onset manic symptoms. For individuals using cannabis alongside SSRIs or other medications, this case serves as a reminder that multiple substance interactions can occur and contribute to mood destabilization, emphasizing the need for comprehensive medical supervision and open communication with healthcare providers about all substances being consumed.